{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:26:23Z","timestamp":1794479183600,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011948","name":"Abbott Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ahj.2026.107474","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:23:16Z","timestamp":1778282596000},"page":"107474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Left atrial appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trial"],"prefix":"10.1016","volume":"300","author":[{"given":"Roza","family":"Saraei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Osmancik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jury","family":"Schewel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedat","family":"Schwenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Latus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffi","family":"Bekeredjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Georg","family":"Haeusler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Paitazoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Sigusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Skurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Rychlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stiermaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-246X","authenticated-orcid":false,"given":"Ingo","family":"Eitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.ahj.2026.107474_bib0001","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2026.107474_bib0002","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ahj.2026.107474_bib0003","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study","volume":"64","author":"Bonde","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2026.107474_bib0004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jacc.2019.10.059","article-title":"Oral anticoagulation for patients with atrial fibrillation on long-term hemodialysis","volume":"75","author":"Kuno","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2026.107474_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034176","article-title":"Anticoagulation for patients with concomitant atrial fibrillation and end-stage renal disease: a systematic review and network meta-analysis","volume":"13","author":"Kao","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.ahj.2026.107474_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70120","article-title":"Oral anticoagulant therapy for patients with atrial fibrillation on long-term dialysis: a Network Meta-analysis of 137,574 Patients","volume":"55","author":"Du","year":"2025","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.ahj.2026.107474_bib0007","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41581-022-00542-7","article-title":"Epidemiology of haemodialysis outcomes","volume":"18","author":"Bello","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.ahj.2026.107474_bib0008","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","article-title":"A randomized controlled trial comparing Apixaban with the vitamin K antagonist phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study","volume":"147","author":"Reinecke","year":"2023","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ahj.2026.107474_bib0009","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","article-title":"Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial","volume":"146","author":"Pokorney","year":"2022","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ahj.2026.107474_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae270","article-title":"Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation","volume":"17","author":"Heine","year":"2024","journal-title":"Clin kidney j"},{"issue":"11","key":"10.1016\/j.ahj.2026.107474_bib0011","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.113.004777","article-title":"Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis","volume":"129","author":"Shah","year":"2014","journal-title":"Circulation"},{"issue":"9689","key":"10.1016\/j.ahj.2026.107474_bib0012","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ahj.2026.107474_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2026.107474_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2026.107474_bib0015","first-page":"610","article-title":"Left atrial appendage closure in end-stage renal disease and hemodialysis: data from a German Multicenter Registry","volume":"101","author":"Fink","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107474_bib0016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijcard.2018.03.083","article-title":"Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: peri-procedural outcomes from an Italian dialysis population","volume":"262","author":"Genovesi","year":"2018","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2026.107474_bib0017","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00392-023-02359-1","article-title":"Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"113","author":"Flores-Umanzor","year":"2024","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2026.107474_bib0018","article-title":"Left atrial appendage occlusion vs anticoagulants in dialysis with atrial fibrillation","volume":"8","author":"Dhar","year":"2025","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ahj.2026.107474_bib0019","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/ckj\/sfad221","article-title":"Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study","volume":"16","author":"Genovesi","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ahj.2026.107474_bib0020","unstructured":"Left atrial appendage occlusion vs. usual Care in patients with atrial fibrillation and severe chronic kidney disease (WatchAFIB) 2014 Available from: https:\/\/classic.clinicaltrials.gov\/show\/NCT02039167. Accessed April 21, 2026."},{"key":"10.1016\/j.ahj.2026.107474_bib0021","unstructured":"The strategy to prevent hemorrhage associated with anticoagulation in renal management (STOP HARM) trial 2016 Available from: http:\/\/classic.clinicaltrials.gov\/show\/NCT02885545. Accessed April 21, 2026."},{"issue":"11","key":"10.1016\/j.ahj.2026.107474_bib0022","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2024.10.101","article-title":"5-Year results from the AMPLATZER amulet left atrial appendage occluder randomized controlled trial","volume":"85","author":"Lakkireddy","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2026.107474_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jacc.2025.03.535","article-title":"3-Year clinical outcomes comparing the Amulet vs Watchman FLX for left atrial appendage closure in patients with atrial fibrillation: results from the SWISS-APERO randomized clinical trial","volume":"86","author":"Galea","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2026.107474_bib0024","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2020111566","article-title":"Safety and efficacy of vitamin K antagonists versus Rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial","volume":"32","author":"De Vriese","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ahj.2026.107474_bib0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1681\/ASN.0000000000000495","article-title":"Anticoagulation for patients with atrial fibrillation receiving dialysis: a pilot randomized controlled trial","volume":"36","author":"Harel","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.ahj.2026.107474_bib0026","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf198","article-title":"Left atrial appendage occlusion in patients with end-stage renal disease: an individual patient-level meta-analysis","volume":"27","author":"Rodriguez-Riascos","year":"2025","journal-title":"Europace"},{"issue":"21","key":"10.1016\/j.ahj.2026.107474_bib0027","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jcin.2025.07.038","article-title":"Outcomes of stroke prevention strategies in patients with atrial fibrillation and end-stage renal disease","volume":"18","author":"Al-Abcha","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.ahj.2026.107474_bib0028","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jcin.2025.08.028","article-title":"Left atrial appendage occlusion in atrial fibrillation and end-stage kidney disease: closing the evidence gap?","volume":"18","author":"Eitel","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107474_bib0029","article-title":"Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: rationale and design of the prospective randomized CLOSURE-AF Trial","volume":"292","author":"Landmesser","year":"2025","journal-title":"Am Heart J"},{"issue":"13","key":"10.1016\/j.ahj.2026.107474_bib0030","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa2513310","article-title":"Left atrial appendage closure or medical therapy in atrial fibrillation","volume":"394","author":"Landmesser","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107474_bib0031","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2023.05.022","article-title":"Rationale and design of a randomized study comparing the watchman FLX Device to DOACs in patients with atrial fibrillation","volume":"264","author":"Kar","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107474_bib0032","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2517213","article-title":"Left atrial appendage closure or anticoagulation for atrial fibrillation","author":"Doshi","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107474_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2026.107367","article-title":"Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: rationale and design of the CATALYST trial","volume":"296","author":"Reddy","year":"2026","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326001365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326001365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:31:41Z","timestamp":1794475901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326001365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S0002870326001365"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107474","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left atrial appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107474"}}